Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.21.4
Condensed Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Assets    
Current asset – cash $ 535,832 $ 35,614
Prepaid expenses 273,538  
Deferred offering costs   469,160
Total current assets 809,370 504,774
Prepaid expenses, non-current 80,548  
Cash and securities held in Trust Account 276,083,453  
Total Assets 276,973,371 504,774
Current Liabilities:    
Accrued offering costs and expenses 243,422 330,300
Due to related party 48,986  
Promissory note - related party 150,000 150,000
Total current liabilities 442,408 480,300
Deferred underwriting discount 9,660,000  
Total liabilities 10,102,408 480,300
Commitments
Common Stock subject to possible redemption, 27,600,000 and zero shares at redemption value, respectively 276,000,000  
Stockholders' Equity:    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding 0 0
Common stock, $0.0001 par value; 100,000,000 shares authorized; 6,900,000 shares issued and outstanding 690 690
Additional paid-in capital   24,310
Accumulated deficit (9,129,727) (526)
Total Stockholders' Equity (Deficit) (9,129,037) 24,474
Total Liabilities and Stockholders' Equity (Deficit) $ 276,973,371 $ 504,774